EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardamine flexuosa extract attenuates neutrophilic airway inflammation in a CSE/LPS-induced murine model

So Yeon Kim, Yoo Kyong Han, Dong-Seon Kim, Won-Kyung Yang, Seung-Hyung Kim, Eunjung Son, Yoon-Young Sung

Frontiers in Pharmacology · 02.11.2026 · 17

DOI: 10.3389/fphar.2026.1897816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 02.11.2026. Verfasst von So Yeon Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic obstructive pulmonary disease (COPD) is a leading cause of disease- related mortality worldwide and is characterized by progressive airflow limitation accompanied by persistent neutrophilic airway inflammation. Macrophage activation plays a key role in this process through the production of pro- inflammatory mediators and neutrophil-attracting chemokines.

Methods

This study investigated the anti-inflammatory effects of Cardamine flexuosa extract (CFE) in macrophage and cigarette smoke extract (CSE)/lipopolysaccharide (LPS)- induced models, with emphasis on macrophage inflammatory responses and neutrophilic airway inflammation.

Results

In LPS-stimulated RAW 264.7 macrophages, CFE reduced nitric oxide production by 77.8% and decreased the secretion of TNF-α, IL-1β, IL-6, and matrix metalloproteinases (MMPs), accompanied by reduced MAPK phosphorylation. In a murine model induced by intranasal administration of CSE and LPS, oral CFE reduced total inflammatory cell and neutrophil counts in bronchoalveolar lavage fluid (BALF) by 53.9% and 82.9%, respectively, at 200 mg/kg compared with the CSE/LPS group. These effects were associated with reduced pulmonary expression of CXCL-1 and MIP-2 and decreased MAPK phosphorylation. Histological analysis demonstrated attenuation of inflammatory cell infiltration and mucus hypersecretion.

Conclusion

These findings demonstrate that CFE attenuates macrophage inflammatory responses and neutrophilic airway inflammation in the CSE/LPS-induced murine model, accompanied by reduced inflammatory mediator production and MAPK activation.

Schlagwörter

Stichwörter der Autor:innen

COPDMAPK signalingcardamine flexuosamacrophage activationneutrophilic inflammation

Autor:innen und Institutionen

  • KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
  • Department of Korean Convergence Medical Science, University of Science and Technology, Daejeon, Republic of Korea.
  • Industry-University Cooperation Foundation, Daejeon University, Daejeon, Republic of Korea.

Zitieren

APA

Kim, S. Y., Han, Y. K., Kim, D. S., Yang, W. K., Kim, S. H., Son, E., & Sung, Y. Y. (2026). Cardamine flexuosa extract attenuates neutrophilic airway inflammation in a CSE/LPS-induced murine model. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1897816

Vancouver

Kim SY, Han YK, Kim DS, Yang WK, Kim SH, Son E, et al. Cardamine flexuosa extract attenuates neutrophilic airway inflammation in a CSE/LPS-induced murine model. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1897816

BibTeX
@article{Kim2026,
  author = {Kim, So Yeon and Han, Yoo Kyong and Kim, Dong-Seon and Yang, Won-Kyung and Kim, Seung-Hyung and Son, Eunjung and Sung, Yoon-Young},
  title = {Cardamine flexuosa extract attenuates neutrophilic airway inflammation in a CSE/LPS-induced murine model},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1897816}
}
Kostenlos starten →